Blog

Welcome to our Blog, where you can stay up to date with all the latest from RLS
Radiopharmacies. You will find company news and articles providing exclusive insights
into what's happening within the radiopharmaceutical industry.

Blogs

RLS Expands by Offering Radiopharmaceutical Contract Development and Manufacturing (rCDMO) Services

The nation’s only Joint Commission-accredited radiopharmacy network is bringing life-saving nuclear medicines closer to patients RLS Radiopharmacies, the only Joint Commission-accredited radiopharmacy network in the U.S., announced it is expanding its business operations with the addition of radiopharmaceutical contract development and manufacturing (rCDMO) services. The new offering will enable RLS […]

Read More

What the Radiopharmaceutical Pipeline Means for Patient Care

With increased access to cutting-edge imaging, improved treatment options, greater personalization of treatment, reduced radiation exposure, and potential for future advances, patients can expect to receive more advanced medical care tailored to their specific needs through radiopharmaceuticals.

Read More

The Supply and Availability of Radiopharmaceuticals

These medical isotope-fueled compounds are being used for the diagnosis and treatment of cancer, neurological disorders, and cardiovascular disease.

Read More

RADIOPHARMACY NETWORK RLS ANNOUNCES EXECUTIVE APPOINTMENTS IN SALES AND HUMAN RESOURCES

Recent Hires Come as Leading Nuclear Pharmacy Network Continues to Expand Capabilities, Enter New Markets and Partner with Industry Pioneers

Read More

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS

SOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients

Read More

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

New Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth

Read More

SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost

Marks Latest Step in RLS Expansion into Oncology & Work to Create an Unbroken Chain of Patient Care from Clinical Trial to Commercial Supply

Read More

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.

LAKE ZURICH, IL., June 5, 2023 /PRNewswire/ — RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc, a leading healthcare improvement company headquartered in Charlotte, North Carolina. […]

Read More

RLS & Evergreen Partnership for Drug Candidate OCTEVY™

Expands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen

Read More

Connect With Us

We’re here to help. If you have an order or account related question or concern, please contact your RLS Account Manager directly or call your local RLS Radiopharmacy at 800 242 8004.

For additional inquiries, please visit our contact page and select from the list below:
General, Business Support, Careers, Media